Die 'EVA'-Studie: Evaluierung der Leistungsfähigkeit diagnostischer Verfahren (Mammographie, Sonographie, MRT) zur sekundären und tertiären Prävention des familiären Mammakarzinoms - Zwischenergebnisse nach der ersten Hälfte der Förderungsperiode

Autor:	C Perlet, Christiane K. Kuhl, Andrea Rieber, Hans-Jürgen Brambs, K. Nüssle-Kügele, D. Nordhoff, H. Sittek, Simone Schrading, N. Morakkabati, Stefanie Weigel, Bernd Tombach, H. H. Schild, Walter Heindel, Claudia Leutner, B Arand
Rok vydání:	2005
Předmět:	Gynecology medicine.medical_specialty medicine.diagnostic_test Breast imaging business.industry Cancer Magnetic resonance imaging medicine.disease Clinical trial Breast cancer medicine Mammography Radiology Nuclear Medicine and imaging Radiology business Prospective cohort study Breast ultrasound
Zdroj:	RöFo - Fortschritte auf dem Gebiet der Röntgenstrahlen und der bildgebenden Verfahren. 177:818-827
ISSN:	1438-9010 1438-9029
DOI:	10.1055/s-2005-858203
Popis:	Purpose To investigate the respective diagnostic accuracies of the different breast imaging modalities, i. e., mammography (Mx), high-frequency breast ultrasound (US), and dynamic contrast-enhanced breast (MRI) regarding the early diagnosis of familial (hereditary) breast cancer. Materials and methods A prospective, non-randomized controlled clinical multi-center trial is performed at 4 academic tertiary care centers in Germany (Ulm, Munchen/Grosshadern, Munster and Bonn) for a total period of 4 years, sponsored by the German Cancer Aid. The protocol consists of semiannual clinical visits and breast ultrasound, and annual bilateral two-view Mx, US and MRI. Imaging studies were first analyzed independently, then Mx was read in conjunction with US, followed by Mx combined with MRI, and finally, all three imaging modalities were read in synopsis. We present the concept and first results of this trial. Results So far, 748 screening rounds are available for analysis in 613 women. A total of 12 breast cancers have been identified, with 11/12 cases in the pTis or pT1/N0 stage. The mean size of detected invasive cancers was 7 mm. A total of 19 benign lesions were biopsied due to false-positive imaging diagnoses. The breast cancer detection rates were: Mx: 5/12 (42 %), US 3/12 (25 %), MRI 10/12 (83 %), and the positive predictive values: Mx 5/17 (29 %), US 3/15 (30 %), and MRI 10/23 (43 %). Conclusion The preliminary data suggest that early diagnosis of familial breast cancer is feasible by intensified surveillance, in particular with the addition of MRI.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::427bb5fdd217cfcc682c018979dad479 https://doi.org/10.1055/s-2005-858203 Zobrazit plný text záznamu